5-Fluorouracil as adjuvant chemotherapy for large bowel cancer is it appropriate for routine community use? S. K. Carter Editorial Pages: 81 - 84
Physiologically based pharmacokinetic models for anticancer drugs H.-S. G. ChenJ. F. Gross General Review Pages: 85 - 94
Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity B. LantzJ. AdolfssonP. Reizenstein Original Articles Pages: 95 - 99
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) A. SantoroG. Bonadonna Original Articles Pages: 101 - 105
Multiple steroid receptors in human breast cancer P. M. MartinP. H. RollandM. Toga Original Articles Pages: 107 - 113
Multiple steroid receptors in human breast cancer P. M. MartinP. H. RollandM. Toga Original Articles Pages: 115 - 120
Comparative metabolism and excretion of adriamycin in man, monkey, and rat P. M. WilkinsonM. IsraelE. Frei III Original Articles Pages: 121 - 125
Bleomycin pharmacokinetics in man D. S. AlbertsH.-S. G. ChenJ. F. Gross Original Articles Pages: 127 - 132
Prednimustine in adult acute myeloid leukaemia L. BrandtI. Könyves Original Articles Pages: 133 - 136
Cytotoxicity of p-chloroamphetamine in dimethylhydrazine-induced carcinomata of rat colon P. J. M. TuttonD. H. Barkla Short Communication Pages: 137 - 138
C.R.O.S. Conference on Combined Modalities Chemotherapy/Radiotherapy S. K. Carter Meeting Report Pages: 139 - 142
